Aims and scope

Targeted Oncology addresses physicians and scientists committed to oncology and cancer research by providing a programme of articles on molecularly targeted pharmacotherapy in oncology. The journal includes:

• Original Research Articles on all aspects of molecularly targeted agents for the treatment of cancer, including immune checkpoint inhibitors and related approaches.
• Comprehensive narrative Review Articles and shorter Leading Articles discussing relevant clinically established as well as emerging agents and pathways.
• Current Opinion articles that place interesting areas in perspective.
• Therapy in Practice articles that provide a guide to the optimum management of a condition and highlight practical, clinically relevant considerations and recommendations.
• Systematic Reviews that use explicit, systematic methods as outlined by the PRISMA statement.
• Adis Drug Reviews of the properties and place in therapy of both newer and established targeted drugs in oncology.